Impact of KRAS mutation on non-small cell lung cancer survival outcomes

被引：0
|
作者：
Thomas, Q. [1 ]
Lemercier, P. [2 ]
Justeau, G. [3 ]
Schneider, S. [4 ]
Filleron, T. [5 ]
Masip, J. Remon [6 ]
Perol, M. [7 ]
Girard, N. [8 ]
Debieuvre, D. [9 ]
Valette, C. Audigier [10 ]
Chouaid, C. [11 ]
Loeb, A. [12 ]
Hiret, S. [13 ]
Clement-Duchene, C. [14 ]
Dansin, E. [15 ]
Stancu, A. T. [16 ]
Dubray-Longeras, P. [17 ]
Pichon, E. [18 ]
Bosquet, L. [19 ]
Quantin, X. [1 ]
机构：
[1] ICM Inst Canc Montpellier, Dept Oncol, Montpellier, France
[2] ICM Inst Canc Montpellier, Biometr Unit, Montpellier, France
[3] CHU Angers, Pneumol, Angers, France
[4] Ctr Hosp Cote Basque, Pyrenees Atlant, Bayonne, France
[5] IUCT Oncopole, Haute Garonne, Inst Claudius Regaud, Toulouse, France
[6] Inst Gustave Roussy, Dept Oncol, Villejuif, France
[7] Ctr Leon Berard, Dept Med Oncol, Lyon, France
[8] Thorax Inst, Inst Curie, Paris, France
[9] GHRMSA, Pneumol, Mulhouse, France
[10] Hop Sainte Musse, Pneumol, Toulon, France
[11] CH Intercommunal Creteil, Pneumol, Creteil, France
[12] Ctr Henri Becquerel, Pneumol, Rouen, France
[13] ICO Inst Cancerol IOuest Rene Gauducheau, Dept Oncol, St Herblain, France
[14] Inst Cancerol Lorraine Alexis Vautrin, Dept Oncol, Vandoeuvre Les Nancy, France
[15] Ctr Oscar Lambret, Dept Oncol, Lille, France
[16] Inst Sainte Catherine, Pneumol, Avignon, France
[17] Ctr Jean Perrin, Pneumol, Clermont Ferrand, France
[18] CHRU Hop Tours, Pneumol, Hop Bretonneau, Tours, France
[19] UNICANCER, Real World Data, Paris, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2433
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1401P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
    Zaorsky, Nicholas G.
    Sun, Yunguang
    Wang, Zixuan
    Palmer, Joshua
    Fortina, Paolo M.
    Solomides, Charalambos
    Werner-Wasik, Maria
    Dicker, Adam P.
    Axelrod, Rita
    Campling, Barbara
    Evans, Nathaniel, III
    Cowan, Scott
    Lu, Bo
    CANCER BIOLOGY & THERAPY, 2013, 14 (10) : 883 - 887
  • [32] A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation
    Wang, Su He
    Cao, Zhengyi
    Farazuddin, Mohammad
    Chen, Jesse
    Janczak, Katarzyna W.
    Tang, Shengzhuang
    Cannon, Jayme
    Baker Jr, James R.
    CANCER GENE THERAPY, 2024, 31 (03) : 464 - 471
  • [33] Frequency of KRAS Subtypes in Non-Small Cell Lung Cancer
    Biernacka, Anna
    Tsongalis, Peter D.
    Peterson, Jason D.
    de Abreu, Francine
    Black, Candice C.
    Gutmann, Edward
    Liu, Xiaoying
    Padmanabhan, Vijayalakshmi
    Tafe, Laura J.
    Amos, Christopher I.
    Tsongalis, Gregory J.
    MODERN PATHOLOGY, 2016, 29 : 451A - 451A
  • [34] Current perspectives of KRAS in non-small cell lung cancer
    Harris, Ethan
    Thawani, Rajat
    CURRENT PROBLEMS IN CANCER, 2024, 51
  • [35] Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
    Tomasini, Pascale
    Walia, Preet
    Labbe, Catherine
    Jao, Kevin
    Leighl, Natasha B.
    ONCOLOGIST, 2016, 21 (12): : 1450 - 1460
  • [36] KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer
    Eklund, Ella A.
    Wiel, Clotilde
    Fagman, Henrik
    Akyurek, Levent M.
    Raghavan, Sukanya
    Nyman, Jan
    Hallqvist, Andreas
    Sayin, Volkan, I
    CANCERS, 2022, 14 (09)
  • [37] Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer
    Moraes, Fabio Y.
    Mansouri, Alireza
    Dasgupta, Archya
    Ramotar, Matthew
    Kosyak, Natalya
    Weiss, Jessica
    Laperriere, Normand
    Millar, Barbara-Ann
    Berlin, Alejandro
    Conrad, Tatiana
    van Prooijen, Monique
    Heaton, Robert
    Coolens, Catherine
    Winter, Jeff
    Bernstein, Mark
    Zadeh, Gelareh
    Kongkham, Paul
    Doherty, Mark
    Shultz, David B.
    LUNG CANCER, 2021, 155 : 34 - 39
  • [38] Impact of race on outcomes of patients with non-small cell lung cancer
    Bryant, Ayesha S.
    Cerfolio, Robert James
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 711 - 715
  • [39] The impact of insurance and race on non-small cell lung cancer outcomes
    Rajyaguru, Devalkumar
    Park, Mijung
    Awais, Omar
    Krauze, Michal Tadeusz
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Impact of Sarcopenia on Surgical Outcomes in Non-small Cell Lung Cancer
    Shuichi Shinohara
    Ryo Otsuki
    Kenichi Kobayashi
    Masakazu Sugaya
    Masaki Matsuo
    Makoto Nakagawa
    Annals of Surgical Oncology, 2020, 27 : 2427 - 2435
12345